Core Viewpoint - The major shareholders of Shanghai Kellytech Medical Technology Co., Ltd. have successfully implemented a shareholding increase plan, reflecting their confidence in the company's future development and long-term investment value [1][2]. Group 1: Shareholding Increase Plan - The plan initiated by Shanghai Xinchengyi Investment Co., Ltd. and Mr. Yuan Zheng aims to increase their holdings by no less than 10,357,781 shares within six months starting from January 20, 2025 [1]. - From January 20 to January 21, 2025, they have already acquired a total of 3,120,710 shares, raising their combined shareholding from 5.6556% to 6.0908% [1]. - The increase plan was completed by July 17, 2025, with a total of shares acquired through centralized bidding transactions [2][3]. Group 2: Shareholding Structure - As of the completion of the increase plan, the total shareholding of Shanghai Xinchengyi, Mr. Yuan Zheng, and their concerted actions increased to 51,908,929 shares, representing 7.2396% of the total shares [4]. - The shareholding before the increase was 40,551,119 shares, which accounted for 5.6556% [4]. - The increase included an additional 1,000,000 shares acquired by Shanghai Zhongyi Investment Co., Ltd. between May 8 and May 9, 2025, totaling 4,319,000 yuan [2][3]. Group 3: Compliance and Regulations - The increase plan adheres to relevant laws and regulations, ensuring that it does not lead to changes in the company's controlling shareholder or actual controller [5]. - The plan includes provisions for adjustments in case of any corporate actions such as dividend distributions or stock splits during the implementation period [3].
ST凯利: 关于持股5%以上股东增持公司股份计划实施结果的公告